NEW YORK (AP) -- Shares of Bio-Reference Laboratories Inc. rose Thursday after the clinical laboratory testing services provider said it had a strong fiscal fourth quarter despite business disruptions ...

A Florida biopharmaceutical and diagnostics company is paying nearly $1.5 billion in stock for Elmwood Park-based diagnostics laboratory firm Bio-Reference Laboratories Inc.OPKO Health Inc. said ...

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of ...

Independent regional clinical laboratory expects net income in the third quarter to be even with the prior year third quarter and hopes to see an improvement in fourth-quarter results over the prior ...

Is Bio-Reference Laboratories Inc (NASDAQ:BRLI) a buy? At the moment, there are dozens of gauges market participants can use to analyze the equity markets. A duo of the most under-the-radar are hedge ...

Keep your eye on margins. Margins matter. The more Bio-Reference Laboratories (Nasdaq: BRLI) keeps of each buck it earns in revenue, the more money it has to invest in growth, fund new strategic plans ...

Although business headlines still tout earnings numbers, many investors have moved past net earnings as a measure of a company's economic output. That's because earnings are very often less ...

Bio-Reference Laboratories (NAS: BRLI) reported earnings on Aug. 30. Here are the numbers you need to know. The 10-second takeaway For the quarter ended July 31 (Q3), Bio-Reference Laboratories met ...